CureVac NV

42
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0015436031
USD
5.12
0.01 (0.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
578.00
58.00
70.00
121.00
55.00
19.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
578.00
58.00
70.00
121.00
55.00
19.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
120.00
122.00
105.00
111.00
62.00
63.00
Operating Expenses
0.00
2.00
3.00
12.00
25.00
1.00
General and Administration Expenses
71.00
88.00
100.00
110.00
55.00
54.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
360.00
362.00
371.00
1,366.00
208.00
137.00
Operating Profit (PBDIT) excl Other Income
218.00
-304.00
-300.00
-1,244.00
-152.00
-117.00
Other Income
-11.00
25.00
42.00
769.00
29.00
7.00
Operating Profit (PBDIT)
231.00
-249.00
-230.00
-434.00
-106.00
-105.00
Interest
0.00
2.00
3.00
12.00
25.00
1.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
24.00
29.00
27.00
40.00
16.00
5.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
206.00
-281.00
-261.00
-487.00
-148.00
-112.00
Provision for Tax
31.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
175.00
-281.00
-261.00
-486.00
-147.00
-111.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.78
-1.27
-1.38
-2.62
-1.11
-0.60
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 896.07% vs -17.98% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 171.73% vs -1.39% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -66.73% vs -30.82% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 162.37% vs -7.47% in Dec 2023

Compare Profit and Loss Results of CureVac NV
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
578.00
351.00
227.00
64.67%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
578.00
351.00
227.00
64.67%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
120.00
0.00
120.00
0%
Operating Expenses
0.00
33.00
-33.00
-100.00%
General and Administration Expenses
71.00
144.00
-73.00
-50.69%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
360.00
255.00
105.00
41.18%
Operating Profit (PBDIT) excl Other Income
218.00
95.00
123.00
129.47%
Other Income
-11.00
5.00
-16.00
-320.00%
Operating Profit (PBDIT)
231.00
102.00
129.00
126.47%
Interest
0.00
33.00
-33.00
-100.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
24.00
2.00
22.00
1,100.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
206.00
65.00
141.00
216.92%
Provision for Tax
31.00
64.00
-33.00
-51.56%
Profit After Tax
175.00
0.00
175.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.7819
0.0055
0.78
14,116.36%
Profit And Loss - Net Sales
Net Sales 578.90 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 896.07% vs -17.98% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 218.70 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 171.73% vs -1.39% in Dec 2023

Profit And Loss - Interest
Interest 0.90 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -66.73% vs -30.82% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 175.44 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 162.37% vs -7.47% in Dec 2023